Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PI left University
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A comparison of pulse wave characteristics, as measured by peripheral tonometry, in pre and post Left Ventricular Assist Device (LVAD) patients.
Pulse waveforms, especially central pressure waveforms, are predictive of cardiovascular events. Peripheral waveforms have been correlated to central waveforms. Peripheral waveforms can be easily measured through applanation tonometry. In this study the investigators hypothesize:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intra-Aortic Balloon Pump (IABP) Group | Advanced Heart Failure and/or pre-LVAD surgical patient with IABP | ||
| IABP/LVAD Group | Post-LVAD surgical patients with IABP | ||
| Post-LVAD Group | LVAD patients 3 months or greater post-implantation undergoing echocardiography | ||
| LVAD Event Group | LVAD patients who have developed LVAD thrombosis or GI hemorrhage related to LVAD | ||
| Arrhythmia group | LVAD patient with an irregular heartbeat. | ||
| Valvular disease group | LVAD patient with valvular heart disease | ||
| Normal control group | Healthy participant without any known heart disease (Control group). |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Observation of pulse wave signatures in LVAD patients | ongoing |
Not provided
Not provided
Inclusion Criteria:
1)18 years of age or older
2)Advanced heart failure as defined by need for IABP or LVAD
3)One or more of the following:
Current inpatient heart failure treatment with intra-aortic balloon pump (IABP)-IABP Group
•≤ 1 week post-LVAD implantation with current IABP support-IABP/LVAD Group
•≥ 3 mo post-LVAD placement and scheduled for LVAD speed optimization with echocardiography.-Post-LVAD Group
Post-LVAD placement with suspected GI hemorrhage or LVAD thrombosis-LVAD Event Group
4)Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care.
Exclusion Criteria:
Not provided
Not provided
Not provided
Advanced heart failure patients, eligible for or currently treated with LVAD, outpatient cardiology clinic or inpatient heart failure service patients
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Peter Eckman, MD | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Univeristy of Minnesota Lillehei Heart Institute | Minneapolis | Minnesota | 55455 | United States |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D013927 | Thrombosis |
| D006470 | Hemorrhage |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |